4.7 Article

Domain adaptation for Alzheimer's disease diagnostics

期刊

NEUROIMAGE
卷 139, 期 -, 页码 470-479

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2016.05.053

关键词

Computer-aided diagnosis; Alzheimer's disease; Classification; Domain adaptation

资金

  1. Humboldt foundation
  2. National Cancer Institute [1K25CA181632-01]
  3. Massachusetts Alzheimer's Disease Research Center [5P50AG005134]
  4. MGH Neurology Clinical Trials Unit
  5. Harvard NeuroDiscovery Center, Genentech [G-40819]
  6. NVIDIA hardware award
  7. A. A. Martinos Center for Biomedical Imaging [P41RR014075, P41EB015896, U24RR021382]
  8. Commonwealth Scientific and Industrial Research Organisation (CSIRO)
  9. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  10. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  11. National Institute on Aging
  12. National Institute of Biomedical Imaging and Bioengineering
  13. Alzheimer's Association
  14. Alzheimer's Drug Discovery Foundation
  15. Araclon Biotech
  16. BioClinica, Inc.
  17. Biogen Idec Inc.
  18. Bristol-Myers Squibb Company
  19. Eisai Inc.
  20. Elan Pharmaceuticals, Inc.
  21. Eli Lilly and Company
  22. EuroImmun
  23. F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.
  24. Fujirebio
  25. GE Healthcare
  26. IXICO Ltd.
  27. Janssen Alzheimer Immunotherapy Research & Development, LLC
  28. Johnson & Johnson Pharmaceutical Research & Development LLC
  29. Medpace, Inc.
  30. Merck Co., Inc.
  31. Meso Scale Diagnostics, LLC
  32. NeuroRx Research
  33. Neurotrack Technologies
  34. Novartis Pharmaceuticals Corporation
  35. Pfizer Inc.
  36. Piramal Imaging
  37. Servier
  38. Synarc Inc.
  39. Takeda Pharmaceutical Company
  40. Canadian Institutes of Health Research
  41. [1S10RR023401]
  42. [1S10RR019307]
  43. [1S10RR023043]

向作者/读者索取更多资源

With the increasing prevalence of Alzheimer's disease, research focuses on the early computer-aided diagnosis of dementia with the goal to understand the disease process, determine risk and preserving factors, and explore preventive therapies. By now, large amounts of data from multi-site studies have been made available for developing, training, and evaluating automated classifiers. Yet, their translation to the clinic remains challenging, in part due to their limited generalizability across different datasets. In this work, we describe a compact classification approach that mitigates overfitting by regularizing the multinomial regression with the mixed l(1)/l(2) norm. We combine volume, thickness, and anatomical shape features from MRI scans to characterize neuroanatomy for the three-class classification of Alzheimer's disease, mild cognitive impairment and healthy controls. We demonstrate high classification accuracy via independent evaluation within the scope of the CADDementia challenge. We, furthermore, demonstrate that variations between source and target datasets can substantially influence classification accuracy. The main contribution of this work addresses this problem by proposing an approach for supervised domain adaptation based on instance weighting. Integration of this method into our classifier allows us to assess different strategies for domain adaptation. Our results demonstrate (i) that training on only the target training set yields better results than the naive combination (union) of source and target training sets, and (ii) that domain adaptation with instance weighting yields the best classification results, especially if only a small training component of the target dataset is available. These insights imply that successful deployment of systems for computer-aided diagnostics to the clinic depends not only on accurate classifiers that avoid overfitting, but also on a dedicated domain adaptation strategy. (C) 2016 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据